Suneel M. Udani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suneel M. Udani has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Jay L. Koyner
Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois
1 shared publication Robert S Dieter
1 shared publication
Latest Publications
- 1 August 2010
- Published by Elsevier in Cardiology Clinics
- Vol. 28 (3) , 453-465
The Effects of Heart Failure on Renal Function
- 1 August 2010
- Published by Elsevier in Cardiology Clinics
- Vol. 28 (3) , 453-465
The Effects of Heart Failure on Renal Function
- 1 July 2008
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 6 (6) , 873-881
Inflammation in renal atherosclerotic disease
The study of renal atherosclerotic disease has conventionally focused on the diagnosis and management of renal artery stenosis. With the increased understanding of atherosclerosis as a systemic inflammatory process, there has been increased interest in vascular biology at the microvasculature level. While different organ beds share some features, the inflammation and injury in the microvasculature of the kidney has unique elements as well. Understanding of the pathogenesis yields a better understanding of the clinical manifestations of renal atherosclerotic disease, which can be very subtle. Furthermore, identifying the molecular mechanisms responsible for the progression of kidney damage can also direct clinicians and scientists toward targeted therapies. Existing therapies used to treat atherosclerotic disease in other vascular beds may also play a role in the treatment of renal atherosclerotic disease.
- 1 July 2008
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 6 (6) , 873-881
Inflammation in renal atherosclerotic disease
The study of renal atherosclerotic disease has conventionally focused on the diagnosis and management of renal artery stenosis. With the increased understanding of atherosclerosis as a systemic inflammatory process, there has been increased interest in vascular biology at the microvasculature level. While different organ beds share some features, the inflammation and injury in the microvasculature of the kidney has unique elements as well. Understanding of the pathogenesis yields a better understanding of the clinical manifestations of renal atherosclerotic disease, which can be very subtle. Furthermore, identifying the molecular mechanisms responsible for the progression of kidney damage can also direct clinicians and scientists toward targeted therapies. Existing therapies used to treat atherosclerotic disease in other vascular beds may also play a role in the treatment of renal atherosclerotic disease.